Earnings Week Puts Money Where the Prints Are
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Options desks are bracing for the busiest earnings week of Q3, with Amazon, Microsoft, and Intel all due to report. Implied volatility across tech is elevated as traders position for binary moves around each print.
Intel is the sharpest read. The stock is up 136% year-to-date yet carries only 3.5% short interest as a percentage of free float. Bears are not present. That sets up an asymmetric call-heavy bias going into results. Any revenue miss could trigger an abrupt sentiment reversal.
CoreWeave carries a very different posture. Short interest sits at 24.8% of free float, and the ORTEX short score is 67. Shares are down 24% year-to-date. Traders pricing in downside have plenty of company. The stock's Q3 report is expected imminently, and with 3.5 days to cover, any squeeze on a beat could be sharp.
Intuitive Surgical was downgraded by analysts this week with multiple target cuts. Its RSI of 70 shows the stock had run hard before the cuts landed. Put positioning into results looks the more crowded side.
The broader EV complex remains toxic for bulls. US plug-in vehicle registrations fell to 21,482 in July 2026, the lowest July figure in four years, according to US state EV fleet data. Lucid Group continues to carry heavy short pressure in that environment.
In index mechanics, TuHURA Biosciences sits just 0.5% above the Russell 2000 entry line ahead of the 30 October cut-off. ORTEX Index Rebalance Radar shows a 91 short score for the name. Any forced buying on inclusion could collide violently with existing short positions.
Stocks in this article
How this article was generated
- Generated
- 25 Oct 2026, 16:41
- Prompt version
- v1.0
- Data sources
- Options flowORTEX Alpha signalsAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.